ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Donaldson, Wilson Lead ASTRO; Thomas To Hear Arguments In Cigarette Case; Doll, Peto Honored

November 8, 1991

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

Carlson Named NCCN Chief Executive

September 28, 2012

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

Davis Denies “Cherry-Picking” Data To Support Her Claims.

August 1, 2008